Table 4:
Age | Alteration | Immunogen | Reference |
---|---|---|---|
P0–7 | ↑ G-CSF, IFNγ, IL-1β, IL-3, IL-6, IL-12(p40), TNF-α; ↓ GM-CSF, IL-1α, IL- 2, IL-3, IL-12(p70) (1) | 20 mg/kg Poly (I:C), i.p. | Garay et al., 2013 |
P8–21 | ↑ TNF-α (1) | 20 mg/kg Poly (I:C), i.p. | Garay et al., 2013 |
↑ IL-2, IL-5, IL-6 (2) | 5 mg/kg Poly (I:C), i.v. (3 consecutive days) | Arsenault et al., 2014 | |
P22–35 | ↑ IL-1β, IL-6, IL-9; Decreased IL-3 (1) | 20 mg/kg Poly (I:C), i.p. | Garay et al., 2013 |
↓ IL-6, TNF-α (3) | 5 mg/kg Poly (I:C), i.v. | Pacheco-López et al., 2011 | |
↑ IL-1β, IL-6 (4) | 25, 25, and 50 μg/kg LPS on 3 consecutive days | Hsueh et al., 2018 | |
P36–60 | ↑ IL-1β, IL-6, IL-10 (4) | 25, 25, and 50 μg/kg LPS on 3 consecutive days | Hsueh et al., 2018 |
>P60 | ↓ IFN-γ, IL-2 (3) | 5 mg/kg Poly (I:C), i.v. | Pacheco-López et al., 2011 |
↑ CCL2, G-CSF, IFNγ, IL-2, IL-6, IL- 13, TNF-α (1) | 3 doses of 0.25 mg/kg Poly I:C-LC, i.v. | Rose et al., 2017 | |
↑ IL-6, IL-17 released by splenic CD4+ T cells upon stimulation (2) | 20 mg/kg Poly (I:C), i.p. | Hsiao et al., 2012 |
Abbreviations: CCL: chemokine (C-C motif) ligand; G-CSF: granulocyte colony-stimulating factor; GM-CSF: granulocyte-macrophage colony-stimulating factor; IFN: interferon
Superscripts indicate methods used to measure cytokines:
Bead-based multiplex assay
Enzyme- linked immunosorbent assay
Multiplexed particle-based flow cytometry assay
Cytometric bead array
For the studies in this table, the immunogen was administered via either intraperitoneal (i.p.) or intravenous (i.v.) injection.